Concomitant inhibition of the thioredoxin system and nonhomologous DNA repair potently sensitizes Philadelphia‐positive lymphoid leukemia to tyrosine kinase inhibitorsLukasz Komorowski, Małgorzata Firczuk, Agnieszka Dąbkowska et al.|HemaSphere|2024Cited by 3
Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor CellsMargaret Nieborowska-Skorska, Tomasz Skórski, Elisabeth Bolton-Gillespie et al.|Blood|2014Cited by 2